-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Pulse Biosciences, Raises Price Target to $74

Benzinga·11/06/2026 19:20:32
Listen to the news
Canaccord Genuity analyst William Plovanic maintains Pulse Biosciences (NASDAQ:PLSE) with a Buy and raises the price target from $58 to $74.